Osteopontin: a bridge between bone and the immune system
- PMID: 12865402
- PMCID: PMC164297
- DOI: 10.1172/JCI19190
Osteopontin: a bridge between bone and the immune system
Erratum in
- J Clin Invest. 2003 Aug;112(4):627
Abstract
The molecular mechanisms underlying the putative role of osteopontin in the chronic inflammatory disease rheumatoid arthritis are unclear. A study in a murine model of arthritis now demonstrates that a specific antibody directed against the exposed osteopontin epitope SLAYGLR is capable of preventing inflammatory cell infiltration in arthritic joints.
Comment on
-
Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis.J Clin Invest. 2003 Jul;112(2):181-8. doi: 10.1172/JCI17778. J Clin Invest. 2003. PMID: 12865407 Free PMC article.
References
-
- Kong YY, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 1999;397:315–323. - PubMed
-
- Simonet WS, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997;89:309–319. - PubMed
-
- Pettit, A.R., and Gravallese, E.M. 2003. Osteoprotegerin. In Targeted therapies in rheumatology. P.E. Lipsky and J.S. Smolen, editors. Martin Dunitz. London, United Kingdom/New York, New York, USA. 359–377.
-
- Denhardt DT, Noda M. Osteopontin expression and function: role in bone remodeling. J. Cell. Biochem. Suppl.>. 1998;30/31:92–102. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
